Supernus Pharm
(SUPN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 73,865 | 1,316 | 60,711 | 53,424 | 126,950 |
| Depreciation Amortization | 82,237 | 85,269 | 90,888 | 50,514 | 31,833 |
| Income taxes - deferred | -20,136 | -25,714 | -26,324 | -4,994 | 568 |
| Accounts receivable | 2,078 | 18,765 | -16,366 | 3,867 | -34,607 |
| Other Working Capital | -2,052 | -9,137 | -24,243 | 3,570 | -36,515 |
| Other Operating Activity | 35,959 | 40,586 | 32,160 | 20,746 | 50,170 |
| Operating Cash Flow | $171,951 | $111,085 | $116,826 | $127,127 | $138,399 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -189,142 | 269,280 | -216,251 | 218,936 | 282,532 |
| PPE Investments | -725 | -551 | -412 | -2,045 | -3,690 |
| Net Acquisitions | N/A | N/A | N/A | -311,692 | -298,541 |
| Purchase Of Investment | N/A | N/A | N/A | 12,888 | -15,000 |
| Investing Cash Flow | $-189,867 | $268,729 | $-216,663 | $-81,913 | $-34,699 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 0 | 93,000 | 0 | N/A | N/A |
| Debt Issued | N/A | N/A | N/A | 800 | 0 |
| Debt Repayment | 0 | -402,500 | 0 | -138,315 | 0 |
| Common Stock Issued | 14,908 | 6,610 | 12,423 | 7,095 | 4,361 |
| Other Financing Activity | -2,715 | -94,990 | -22,900 | 0 | -802 |
| Financing Cash Flow | $12,193 | $-397,880 | $-10,477 | $-130,420 | $3,559 |
| Beginning Cash Position | 75,054 | 93,120 | 203,434 | 288,640 | 181,381 |
| End Cash Position | 69,331 | 75,054 | 93,120 | 203,434 | 288,640 |
| Net Cash Flow | $-5,723 | $-18,066 | $-110,314 | $-85,206 | $107,259 |
| Free Cash Flow | |||||
| Operating Cash Flow | 171,951 | 111,085 | 116,826 | 127,127 | 138,399 |
| Capital Expenditure | -725 | -551 | -412 | -2,045 | -3,690 |
| Free Cash Flow | 171,226 | 110,534 | 116,414 | 125,082 | 134,709 |